ALB and central nervous system cancer: We have previously reported a glioma targeted cell-penetrating peptide-modified albumin NP (termed L-BSA NP).16 It would be an interesting observation to compare the in vivo fate of the L-BSA NP and T12/Man-BSA NP, and thus a pharmacokinetics study in rats was performed.